Shares of Aurobindo Pharma fall as Nifty gains

Shares of Aurobindo Pharma fall as Nifty gains
ETMarkets.com
Rate Story
Share
Font Size
Save
Comment
Synopsis

On the technical charts, the 200-day moving average of the stock stood at Rs 534.41.

A man walks past the Bombay Stock Exchange (BSE) building in MumbaiReuters
Stocks in focus: RIL, Tata Motors, Infosys, IIFL Securities, Apollo Hospitals, Punjab National Bank, NBCC and more..
Shares of . slipped 1.22 per cent to Rs 440.8 in Tuesday's trade as of 01:58PM (IST). It hit a high of Rs 447.15 and low of Rs 438.9 during the session.

The stock quoted a 52-week high price of Rs 730.0 and a low of Rs 429.3. The return on equity for the stock stood at 10.77 per cent. About 17,929 shares have changed hands on the counter so far.

The stock's beta value, which measures its volatility in relation to the broader market, stood at 1.06.

The scrip has been an underperformer, down 35.72 per cent in the past one year in comparison with a 1.12 per cent gain in Sensex.

Technicals
On the technical charts, the 200-day moving average (DMA) of the stock stood at Rs 429.3 on January 17, while the 50-DMA was at Rs 456.52. If a stock trades well above 50-DMA and 200-DMA, it usually means the immediate trend is upward. On the other hand, if the stock trades well below 50-DMA and 200-DMA both, it is considered a bearish trend and if trades between these averages, then it suggests the stock can go either way.

Promoter/FII Holding
Promoters held 48.76 per cent stake in Aurobindo Pharma Ltd. as of 30-Sep-2022. Mutual funds and foreign institutional investors held 9.82 per cent and 20.71 per cent stake.
Experience Your Economic Times Newspaper, The Digital Way!

Read More News on

(What's moving Sensex and Nifty Track latest market news, stock tips and expert advice on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds.)

Download The Economic Times News App to get Daily Market Updates & Live Business News.

...more
Pick the best stocks for yourself
Powered by
Read before you invest. Insights on Aurobindo Pharma Ltd.. Explore Now